logo
logo

Biocompare, A Division Of Comparenetworks, Acquires Chromocyte

Nov 25, 2021over 3 years ago

Acquiring Company

Biocompare

Acquired Company

Chromocyte

Description

CompareNetworks, Inc., a leading provider of online B2B marketplaces for the scientific and healthcare industries, today announced the asset acquisition of Chromocyte Limited, a website that serves the flow cytometry community and market.

Company Information

Company

Biocompare

About

Biocompare

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed